• $385,905.00
    Market Cap
  • -87.50%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
09/30/2023
09/30/2022
09/30/2021
09/30/2020
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-92,247
+10.02%
-83,842
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
314
-80.80%
1,635
N/A
Total Operating Expenses
4.2M
+3,104.09%
-141,088
-156.93%
247,814
-95.44%
5.4M
N/A
Operating Profit
-4.2M
-3,104.09%
141,088
+156.93%
-247,814
-95.44%
-5.4M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-212,972
-77.37%
-940,993
+82.40%
-515,907
+1,145.01%
-41,438
N/A
Interest Income and Expense and Net
-212,972
-77.37%
-940,993
+82.40%
-515,907
+1,145.01%
-41,438
N/A
Total Nonoperating Income and Expense
-204,121
-75.34%
-827,676
+54.05%
-537,268
-778.78%
79,152
N/A
Income before Taxes
-4.2M
-3,104.09%
141,088
+156.93%
-247,814
-95.37%
-5.3M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
-3,034
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-4.4M
+547.05%
-686,588
-21.62%
-875,998
-83.62%
-5.3M
N/A
Net Income from Continuing Operations Applicable to Common
-4.4M
+547.05%
-686,588
-21.62%
-875,998
-83.63%
-5.3M
N/A
Basic EPS and Net Income
-0.01
0.00%
-0.01
0.00%
-0.01
-87.50%
-0.08
N/A
Diluted EPS and Net Income
-0.01
0.00%
-0.01
0.00%
-0.01
-87.50%
-0.08
N/A
Basic Weighted Average Shares
578.0M
+418.75%
111.4M
+61.70%
68.9M
0.00%
68.9M
N/A
Diluted Weighted Average Shares
578.0M
+418.75%
111.4M
+61.70%
68.9M
0.00%
68.9M
N/A
Balance Sheet
Cash and Cash Equivalents
74,986
+90.50%
39,363
+262.86%
10,848
-23.83%
14,241
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
74,986
+90.50%
39,363
+262.86%
10,848
-23.83%
14,241
N/A
Total Current Assets
95,657
+12.17%
85,276
+91.30%
44,577
+36.61%
32,630
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
314
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
314
N/A
Total Assets
95,657
+12.17%
85,276
+91.30%
44,577
+35.31%
32,944
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
202,466
-32.99%
302,142
-70.21%
1.0M
+62.28%
624,880
N/A
Total Current Liabilities
2.1M
+21.98%
1.7M
-39.90%
2.8M
+28.03%
2.2M
N/A
Total Long-Term Debt
183,291
+99.30%
91,967
-85.52%
635,086
+77.80%
357,196
N/A
Total Long-Term Liabilities
86,400
N/A
N/A
N/A
38,018
N/A
N/A
N/A
Total Liabilities
2.1M
+15.65%
1.8M
-36.61%
2.8M
+3.35%
2.7M
N/A
Retained Earnings
-28.7M
+18.34%
-24.2M
+2.92%
-23.5M
+3.87%
-22.7M
N/A
Total Stockholders Equity
-2.0M
+15.83%
-1.7M
-38.68%
-2.8M
+2.96%
-2.7M
N/A
Total Shares Outstanding
771.8M
+328.83%
180.0M
+161.19%
68.9M
0.00%
68.9M
N/A
Cash Flow
Cash from Operating Activities
-8,516
-97.28%
-312,663
+6.57%
-293,393
+16.74%
-251,327
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
44,139
-87.06%
341,178
+17.65%
290,000
+34.57%
215,500
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-4,910.70%
+364.38%
-1,057.48%
-53.21%
-2,260.03%
+952.27%
-214.78%
N/A
Return on Equity
243.79%
+688.71%
30.91%
-4.22%
32.27%
-99.59%
7,786.26%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.05
-8.09%
0.05
+218.87%
0.02
+6.71%
0.01
N/A
Cash Ratio
0.04
+56.41%
0.02
+500.00%
0.004
-40.00%
0.007
N/A
Debt-to-Equity Ratio
-0.20
-15.51%
-0.23
-61.03%
-0.60
+63.10%
-0.37
N/A
Debt-to-Assets Ratio
4.03
-12.74%
4.62
-87.51%
37.00
+24.10%
29.81
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow